Around 14 per cent of Sweden’s population lives with obesity, and just over half are overweight or obese. Obesity increases the risk of diabetes, cardiovascular disease and certain types of cancer, among other conditions. In 2023, the costs to society were estimated at SEK 80–125 billion, according to IHE and the Swedish Public Health Agency, respectively.
Catharina Barkman: Health gains that transform lives and economies
Novo Nordisk has not only transformed obesity treatment but also made its mark on Denmark’s economy. Sweden has a long history of medical innovation, but how can we create the conditions for the next major success? Catharina Barkman explores the question in her latest column.
Advertisement